The Proteins Assays Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Proteins Assays Market is estimated to be USD 1.28 million in 2016 and predicted to rise to USD 2.17 million by 2021 with a CAGR of 11.1%. The market is segmented by Product (Reagents, Kits, Instruments), Type (Dye-Binding, Copper-Ion Based, Test Strip), Technology (Absorbance, Colorimetric, Fluorescence), Application (Drug Discovery, Diagnosis) and End Users (Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals, Clinical Laboratories). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
Factors responsible for the growth of market are increasing expenditure on pharmaceutical and biological R&D, increase in government funding and initiatives, increasing incidence rate of chronic diseases like cardiovascular, neurological and other infectious diseases, rapid technological advancements in protein assay techniques. On the other hand, unapproved bipolar drugs, stringent regulatory framework and adverse drug reactions of anticonvulsants may hinder the growth of market.
Dye binding proteins assays segment holds the major share in the market based on type, due to increasing usage of dye-binding assays in disease diagnosis. Absorbance-based proteins assays held major share in the market based on technology due to increasing sensitivity and accuracy of this technology.
North America is leading the market while Europe is at second place. Growth in Pharmaceutical and biotechnological industries, strong trend of R&D in life sciences industry, increasing private-public partnership for drug development has helped these regions dominate the market. Asia Pacific is expected to grow the fastest due to increasing research funding, growing proteomics and genomics techniques and rising adoption of advanced Proteins Assays techniques
Some of the key players dominating this market include Abcam PLC., Bio-Rad Laboratories Inc., Biovision Inc., Cell Signaling Technology Inc, GE Healthcare, PerkinElmer Inc., Thermo Fisher Scientific, Geno Technology Inc., Lonza Group, Merck KGaA, Novus Biologicals, LLC.
Browse through the full report at https://www.marketdataforecast.com/market-reports/proteins-assays-market-3060/ and checkout our recent reports in the Diagnostics https://www.marketdataforecast.com/subcategory/diagnostics-5/ For more insights and up-to-date industry news don’t forget subscribing to our newsletters.